Literature DB >> 11847164

Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.

Y Matsumura1, P M Elliott, M S Virdee, P Sorajja, Y Doi, W J McKenna.   

Abstract

BACKGROUND: Conventional Doppler indices of left ventricular diastolic function do not correlate with symptoms or exercise capacity in patients with hypertrophic cardiomyopathy, because of their dependence on loading conditions. Diastolic mitral annular velocity measured using Doppler tissue imaging has been reported to be a preload independent index of left ventricular diastolic function.
OBJECTIVE: To determine the relation between diastolic annular velocities combined with conventional Doppler indices and symptoms or exercise capacity in hypertrophic cardiomyopathy.
METHODS: 85 patients with hypertrophic cardiomyopathy and 60 normal controls were studied. Diastolic mitral annular velocities, transmitral left ventricular filling, and pulmonary venous velocities were measured.
RESULTS: Early diastolic velocities at lateral and septal annulus were lower in patients with hypertrophic cardiomyopathy than in controls (lateral Ea: 10 (3) v 18 (4) cm/s, p < 0.0001; septal Ea: 7 (2) v 12 (3) cm/s, p < 0.0001). Unlike conventional Doppler indices alone, transmitral early left ventricular filling velocity (E) to lateral Ea ratio correlated inversely with peak oxygen consumption (r = -0.42, p < 0.0001). Patients in New York Heart Association (NYHA) class III had a higher transmitral E to lateral Ea ratio (12.0 (4.6)) than those in NYHA class II (7.6 (3.1), p < 0.005) or class I (6.6 (2.6), p < 0.0001).
CONCLUSIONS: Early diastolic mitral annular velocities are reduced in patients with hypertrophic cardiomyopathy. Unlike conventional Doppler indices alone, the transmitral E to lateral Ea ratio correlates with NYHA functional class and exercise capacity.

Entities:  

Mesh:

Year:  2002        PMID: 11847164      PMCID: PMC1767026          DOI: 10.1136/heart.87.3.247

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  37 in total

1.  Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function.

Authors:  C Briguori; S Betocchi; M Romano; F Manganelli; M Angela Losi; Q Ciampi; R Gottilla; R Lombardi; M Condorelli; M Chiariello
Journal:  Am J Cardiol       Date:  1999-08-01       Impact factor: 2.778

2.  Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy.

Authors:  S F Nagueh; N M Lakkis; K J Middleton; W H Spencer; W A Zoghbi; M A Quiñones
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

3.  Detection of left ventricular regional relaxation abnormalities and asynchrony in patients with hypertrophic cardiomyopathy with the use of tissue Doppler imaging.

Authors:  T Oki; Y Mishiro; H Yamada; Y Onose; M Matsuoka; T Wakatsuki; T Tabata; S Ito
Journal:  Am Heart J       Date:  2000-03       Impact factor: 4.749

4.  Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures.

Authors:  O Rossvoll; L K Hatle
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

5.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

Authors:  B J Maron; J S Gottdiener; S E Epstein
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

6.  Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy.

Authors:  S Severino; P Caso; M Galderisi; L De Simone; A Petrocelli; O de Divitiis; N Mininni
Journal:  Am J Cardiol       Date:  1998-12-01       Impact factor: 2.778

7.  Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study.

Authors:  J E Sanderson; T A Traill; M G Sutton; D J Brown; D G Gibson; J F Goodwin
Journal:  Br Heart J       Date:  1978-06

8.  Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis.

Authors:  M G Sutton; A J Tajik; D G Gibson; D J Brown; J B Seward; E R Guiliani
Journal:  Circulation       Date:  1978-03       Impact factor: 29.690

9.  [Left ventricular wall motion dynamics of asymmetric septal hypertrophy: assessment by intramyocardial pulsed Doppler echocardiography].

Authors:  Y Hada; N Itoh; M Asakawa; H Ikenouchi; E Tamiya; H Kiritani
Journal:  J Cardiol       Date:  1998-06       Impact factor: 3.159

10.  Hypertrophic nonobstructive cardiomyopathy: a precise assessment of hemodynamic characteristics and clinical implications.

Authors:  Y Hirota; K Furubayashi; K Kaku; G Shimizu; M Kino; K Kawamura; T Takatsu
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

View more
  30 in total

1.  Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Martin S Maron; Eshan A Patvardhan; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

2.  Effects of exercise on the duration of diastole and on interventricular phase differences in patients with hypertrophic cardiomyopathy: relationship to cardiac output reserve.

Authors:  Gunnar Plehn; Julia Vormbrock; Axel Meissner; Hans-Joachim Trappe
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

3.  Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Filippo Maria Cauti; Beatrice Musumeci; Gabriele Egidy Assenza; Carlo Nicola De Cecco; Giuseppe Muscogiuri; Antonello Maruotti; Agnese Ricotta; Erika Pagannone; Laura Marino; Daria Santini; Giulia Proietti; Andrea Serdoz; Francesco Paneni; Massimo Volpe; Camillo Autore
Journal:  Intern Emerg Med       Date:  2012-10-07       Impact factor: 3.397

Review 4.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

5.  The presence and impact of diastolic dysfunction on physical function and body composition in hemodialysis patients.

Authors:  Jin Hee Jeong; Pei-Tzu Wu; Brandon Michael Kistler; Peter John Fitschen; Annabel Guzman Biruete; Shane Aaron Phillips; Mohamed M Ali; Bo Fernhall; Kenneth Robert Wilund
Journal:  J Nephrol       Date:  2015-03-10       Impact factor: 3.902

6.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 7.  Cardiac Imaging in the Athlete: Shrinking the "Gray Zone".

Authors:  Mario R Caruso; Lohit Garg; Matthew W Martinez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-03

Review 8.  Experimental therapies in hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  J Cardiovasc Transl Res       Date:  2009-10-01       Impact factor: 4.132

Review 9.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

10.  The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy.

Authors:  Taliha Öner; Rahmi Özdemir; Filiz Hazan; Cem Karadeniz; Önder Doksoz; Murat Muhtar Yilmazer; Timur Meşe; Vedide Tavli
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.